Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators conducted a randomized, Double blind, and Controlled Study to evaluate the Efficacy and safety of Lidocaine Infusion Treatment in Management of Neuropathic pain.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: Ministry of Food and Drug Safety, Korea
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• postherpetic neuralgia, diabetic polyneuropathy, peripheral neuropathy

• NRS score > 4

• stable oral medication during the 1 month trial period

• volunteers with informed consent

Exclusion Criteria:

• pregnancy, breastfeeding, possibility of pregnancy

• pain from causes other than upper 3 indications

• hypersensitivity to lidocaine or other local anesthetics

• important disease of heart, kidney, liver or incurable disease that may affect the assessment of adverse effects, or may interfere with the completion of study

• severe conduction block

• history of other interventions that may affect the study

• Enrollment in other clinical trials within 30 days

• otherwise not suitable to study